SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001015820-24-000078
Filing Date
2024-09-03
Accepted
2024-09-03 16:16:40
Documents
4
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 6-K form6-kxconvertibledebtlau.htm 6-K 21370
2 EX-99.1 exhibit99109032024pressrel.htm EX-99.1 29049
3 image_0a.jpg GRAPHIC 54221
4 qiagen_logo.jpg GRAPHIC 69764
  Complete submission text file 0001015820-24-000078.txt   221935
Mailing Address HULSTERWEG 82 PL VENLO P7 5912
Business Address HULSTERWEG 82 PL VENLO P7 5912 31-77-35566-00
QIAGEN N.V. (Filer) CIK: 0001015820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38332 | Film No.: 241274281
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)